Heart Failure
Showing NaN - NaN of 104
Heart Failure, CHF, Chronic Heart Disease Trial in United States (Optimizer Smart System)
Terminated
- Heart Failure
- +3 more
- Optimizer Smart System
-
Mesa, Arizona
- +16 more
Nov 21, 2021
Heart Failure, Iron-deficiency Trial in Worldwide (Ferric Carboxymaltose, Placebo)
Active, not recruiting
- Heart Failure
- Iron-deficiency
- Ferric Carboxymaltose
- Placebo
-
Alexander City, Alabama
- +345 more
Nov 12, 2021
Heart Failure Trial in Worldwide (Omecamtiv Mecarbil, Placebo, Standard of Care)
Completed
- Heart Failure
- Omecamtiv Mecarbil
- +2 more
-
Birmingham, Alabama
- +1033 more
Nov 2, 2021
Heart Failure Trial in Columbus (R Drink)
Completed
- Heart Failure
- R Drink
-
Columbus, OhioOhio State University Wexner Medical Center
Oct 18, 2021
Heart Failure Trial in Worldwide (Placebo, Omecamtiv mecarbil)
Completed
- Heart Failure
- Placebo
- Omecamtiv mecarbil
-
Mobile, Alabama
- +149 more
Jul 25, 2021
Heart Failure, Cardiac Failure, Acute Decompensated Heart Failure (ADHF) Trial in United States (Isolated veno-venous
Terminated
- Heart Failure
- +2 more
- Isolated veno-venous ultrafiltration (AQ)
- IV Loop Diuretics (LD)
-
Huntsville, Alabama
- +37 more
May 18, 2021
CHF, Heart Failure, Heart Disease, Ischemic Trial in United States (3 x 10e13vg NAN-101)
Recruiting
- Congestive Heart Failure
- +8 more
- 3 x 10e13vg NAN-101
-
Minneapolis, Minnesota
- +3 more
Jun 3, 2021
Hyperkalemia, Heart Failure Trial in Worldwide (patiromer, )
Heart Failure Trial in Worldwide (Empagliflozin, Placebo)
Heart Failure Trial in United States (Elevated night pacing on, Elevated night pacing off)
Completed
- Heart Failure
- Elevated night pacing on
- Elevated night pacing off
-
Tucson, Arizona
- +9 more
Apr 16, 2021
Heart Failure Trial in United States (Rheos® system)
Completed
- Heart Failure
- Rheos® system
-
Mobile, Alabama
- +21 more
Apr 7, 2021
Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)
Completed
- Heart Failure
- Vericiguat (BAY1021189) (1.25 mg)
- +2 more
-
Fountain Valley, California
- +156 more
Mar 2, 2021
Heart Failure Trial in Worldwide (Sentus QP left ventricular lead)
Terminated
- Heart Failure
- Sentus QP left ventricular lead
-
Fairhope, Alabama
- +118 more
Mar 1, 2021
Left Ventricular Assist Devices Using the CardioMEMS™
Completed
- Heart Failure
- Hemodynamic management using CardioMEMS
-
La Jolla, California
- +22 more
Jan 7, 2021
(CRT) Based Heart Failure Monitoring Study
Completed
- Heart Failure
- Cardiac Resynchronization Therapy
- HeartPOD™ System
-
Los Angeles, California
- +9 more
Oct 9, 2020
Heart Failure Trial in Worldwide (Attain Stability Quad Left Ventricular Pacing Lead)
Completed
- Heart Failure
- Attain Stability Quad Left Ventricular Pacing Lead
-
Phoenix, Arizona
- +49 more
Dec 19, 2019
Heart Failure, Cardiomyopathy, Ventricular Dysfunction Trial in Canada, United States (MPC Intramyocardial Injection, Control
Completed
- Heart Failure
- +2 more
- MPC Intramyocardial Injection
- Control Solution
-
Los Angeles, California
- +18 more
Nov 7, 2019
Heart Failure, Respiratory Insufficiency, Stroke Acute Trial in Worldwide (Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg, Placebo)
Completed
- Heart Failure
- +4 more
- Rivaroxaban, 10 mg
- +2 more
-
Birmingham, Alabama
- +616 more
Nov 5, 2019
Reveal LINQ™ Heart Failure
Completed
- Heart Failure
- Reveal LINQ™ Insertable Cardiac Monitor (ICM)
-
La Jolla, California
- +18 more
Oct 22, 2019
Heart Failure, Cardiac Failure, CHF Trial in Columbus (Brief treatment for Insomnia, Sleep Monitoring)
Unknown status
- Heart Failure
- +8 more
- Brief treatment for Insomnia
- Sleep Monitoring
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Sep 18, 2019
Heart Failure Trial in United States (Chronicle Implantable Hemodynamic Monitor, Standard of Care)
Completed
- Heart Failure
- Chronicle Implantable Hemodynamic Monitor
- Standard of Care
-
Birmingham, Alabama
- +27 more
Aug 13, 2019